[Relationship of the CDKAL1 and KCNQ1 gene polymorphisms to the age at diagnosis of type 2 diabetes in the Slovakian population].

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 21416855)

Published in Vnitr Lek on February 01, 2011

Authors

M Dobríková1, M Javorský, V Habálová, L Klimcáková, M Kozárová, J Zidzik, J Halusková, J Salagovic, I Tkác

Author Affiliations

1: IV interná klinika Lekárskej fakulty UPJS a Centra excelentnosti pre výskum ateroskleróry a jej komplikácil-srdcového a mozgového infarktu Lekárskej fakulty UPJS Kosice, Slovenská republika.

Articles by these authors

Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43

Field mapping without reference scan using asymmetric echo-planar techniques. Magn Reson Med (2000) 3.13

Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain. J Magn Reson (1999) 2.42

Assessment of adrenoleukodystrophy lesions by high field MRS in non-sedated pediatric patients. Neurology (2005) 1.73

[Possible influence of genetic polymorphism in the area of GSTs genes on the serum PCB level]. Vnitr Lek (2013) 1.39

Extracellular-intracellular distribution of glucose and lactate in the rat brain assessed noninvasively by diffusion-weighted 1H nuclear magnetic resonance spectroscopy in vivo. J Cereb Blood Flow Metab (2000) 1.18

Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain. Magn Reson Imaging (1998) 1.18

Noninvasive measurements of [1-(13)C]glycogen concentrations and metabolism in rat brain in vivo. J Neurochem (1999) 1.14

Single-shot, three-dimensional "non-echo" localization method for in vivo NMR spectroscopy. Magn Reson Med (2000) 1.08

Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes. Diabetes Obes Metab (2012) 1.05

Localized in vivo 1H NMR detection of neurotransmitter labeling in rat brain during infusion of [1-13C] D-glucose. Magn Reson Med (1999) 1.02

Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes. Diabetes Obes Metab (2011) 0.92

Microsomal epoxide hydrolase polymorphisms, cigarette smoking and prostate cancer risk in the Slovak population. Neoplasma (2012) 0.84

Allelic and haplotype frequencies of the p53 polymorphisms in brain tumor patients. Physiol Res (2002) 0.83

Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res (2005) 0.83

Metabolic changes in rat brain after prolonged ethanol consumption measured by 1H and 31P MRS experiments. Cell Mol Neurobiol (2000) 0.81

Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer (2001) 0.81

Polymorphism of the p53 gene within the codon 72 in lung cancer patients. Neoplasma (2001) 0.81

Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr (2000) 0.80

Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas. Physiol Res (2012) 0.79

A pilot study testing the genetic polymorphism of N-acetyltransferase 2 as a risk factor in lung cancer. Neoplasma (2005) 0.79

Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients. Neoplasma (2004) 0.79

Motion artifacts reduction in DWI using navigator echoes: a robust and simple correction scheme. MAGMA (1998) 0.78

Molecular detection of Ureaplasma urealyticum infection from clinical urogenital swabs. Folia Microbiol (Praha) (2007) 0.78

Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients. Physiol Res (2005) 0.78

Increased intracranial arterial resistance in patients with type 2 diabetes mellitus. Wien Klin Wochenschr (2001) 0.78

[Strongyloidosis within the framework of mixed parasitoses in a 16-month-old child]. Cesk Pediatr (1986) 0.77

Absolute metabolite quantification by in vivo NMR spectroscopy: III. Multicentre 1H MRS of the human brain addressed by one and the same data-analysis protocol. Magn Reson Imaging (1998) 0.77

Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population. Bratisl Lek Listy (2010) 0.77

Cytogenetic monitoring in coke oven workers. Mutat Res (1998) 0.77

Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis (1998) 0.77

[Hypercoagulation states]. Vnitr Lek (1993) 0.76

The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study. Physiol Res (2016) 0.76

Type IV renal tubular acidosis associated with Alport's syndrome. Postgrad Med J (1993) 0.75

The molecular genetic background of familial hypercholesterolemia: data from the Slovak nation-wide survey. Physiol Res (2016) 0.75

[Echocardiographic findings in patients on a long-term dialysis regimen]. Vnitr Lek (1988) 0.75

Cardiovascular risk factors as predictors of mortality in type II diabetic patients. Wien Klin Wochenschr (1999) 0.75

[Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging]. Klin Onkol (2011) 0.75

Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs. Neoplasma (1998) 0.75

[The present status of treatment of unstable angina pectoris]. Vnitr Lek (1994) 0.75

New approach for quantitation of short echo time in vivo 1H MR spectra of brain using AMARES. NMR Biomed (1998) 0.75

[Relation of polymorphism of genes controlling endothelial function and blood pressure and the occurrence of vascular complications in type 2 diabetes]. Vnitr Lek (2002) 0.75

[Infections of the diabetic foot--etiopathogenesis and possible preventive strategies]. Vnitr Lek (1998) 0.75

[Effect of bisoprolol on heart rate variability in patients with hyperthyroidism]. Vnitr Lek (2000) 0.75

[Pulmonary embolism as a rare complication of a contusion in the inguinal region]. Vnitr Lek (1992) 0.75

[Evans' syndrome]. Vnitr Lek (1988) 0.75

[Neuroendocrine changes in chronic heart failure]. Vnitr Lek (1993) 0.75

[Neurohumoral activity in liver cirrhosis]. Vnitr Lek (1995) 0.75

Gene polymorphisms of renin angiotensin system and serotonin transporter gene in patients with vasovagal syncope. Bratisl Lek Listy (2009) 0.75

Reciprocal adaptive response of human peripheral lymphocytes induced by bleomycine or gamma rays. Physiol Res (1999) 0.75

[Renin-angiotensin system: molecular biology]. Cesk Fysiol (2004) 0.75

[Mutagenic activity of urine of patients with psoriasis treated with pharmaceutical black coal tar]. Cas Lek Cesk (1994) 0.75

[Infection of the diabetic foot--appropriate antibiotics and therapeutic strategies]. Vnitr Lek (1998) 0.75

Nucleic acid amplification technique for detection of Chlamydia trachomatis infection from clinical urogenital swabs. Folia Microbiol (Praha) (2007) 0.75

[Changes in lipoprotein metabolism in patients with diabetes mellitus and the effect on lipid profile in diabetics]. Vnitr Lek (1994) 0.75

p53 single nucleotide polymorphisms and bladder cancer. Neoplasma (2000) 0.75

Spirometric alterations in patients with reduced renal function. Wien Klin Wochenschr (1993) 0.75

[ECG Holter monitoring in patients with chronic renal failure in a long-term dialysis program]. Vnitr Lek (1992) 0.75

[Rapid control of acute hypertensive conditions by administration of sublingual nifedipine]. Vnitr Lek (1986) 0.75